Texas A&M University LibrariesTexas A&M University LibrariesTexas A&M University Libraries
    • Help
    • Login
    OAKTrust
    View Item 
    •   OAKTrust Home
    • University Libraries
    • Business Library and Collaboration Commons
    • Texas A&M University Patents
    • View Item
    •   OAKTrust Home
    • University Libraries
    • Business Library and Collaboration Commons
    • Texas A&M University Patents
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Use of perlecan domain V in treating amyloidogenic disease

    Thumbnail
    View/Open
    9358273.pdf (2.849Mb)
    Date
    2016-06-07
    Author
    Bix, Gregory J.
    Wright, Sarah
    Griswold-prenner, Irene
    Metadata
    Show full item record
    Abstract
    The application reports that perlecan domain V (DV) or the LG3 domain thereof reduces deposition and toxicity of Aβ peptide, the major component of plaques in Alzheimer's disease. Methods of using DV, LG3 and related molecules in treatment of amyloidogenic diseases, particularly Alzheimer's disease, are provided.
    URI
    http://hdl.handle.net/1969.1/177150
    Subject
    A61K 38/39
    Collections
    • Texas A&M University Patents
    Citation
    Bix, Gregory J.; Wright, Sarah; Griswold-prenner, Irene (2016). Use of perlecan domain V in treating amyloidogenic disease. United States. Patent and Trademark Office; Texas A&M University. Libraries. Available electronically from http : / /hdl .handle .net /1969 .1 /177150.

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Advanced Search

    Browse

    All of OAKTrustCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDepartmentThis CollectionBy Issue DateAuthorsTitlesSubjectsDepartment

    My Account

    LoginRegister

    Statistics

    View Usage Statistics
    Help and Documentation

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV